创模生物科技(北京)有限公司

CN / En

NEWS

Features of the Luminex platform from InnoModels Biotechnology

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-11 16:21
  • Views:

(Summary description)InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.

Features of the Luminex platform from InnoModels Biotechnology

(Summary description)InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-11 16:21
  • Views:
Information

Introduction
InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.
Luminex Platform Features
1. Multiple Detection Capabilities
The core strength of the Luminex platform is its powerful multi-detection capability. By utilizing color-coded microspheres and flow cytometry, the platform is capable of simultaneously detecting multiple cytokines, biomarkers, and other immune response-related proteins, dramatically improving experimental efficiency and data richness. For example, quantitative detection of up to 50 indicators can be accomplished with a sample size of only 25 μL, which is significant in research and clinical applications.

 


2. High Sensitivity and Specificity
The Luminex platform ensures high sensitivity and specificity based on its advanced technology principles. Even trace amounts of microorganisms or cytokines can be accurately detected, avoiding false positives or missed detections that can occur with traditional detection methods. This high sensitivity and specificity is especially important for preclinical evaluation of tumor immunotherapy, drug screening and assessment.
3. Simple and efficient operation
The Luminex platform is relatively simple to use and requires no special skills or equipment, which greatly reduces the difficulty and cost of operation. At the same time, the platform offers researchers the convenience of rapid testing, with results typically available in just a few hours. In addition, the platform provides a one-stop service from sample processing to data analysis, ensuring an efficient testing process.
4. Wide range of applications
The Luminex platform has a wide range of applications, not only for disease treatment and monitoring in the medical field, but also for environmental protection, food safety and many other fields. In the field of scientific research, the platform can be used in mouse modeling to study the pathogenesis of diseases and evaluate the activity/mechanism of action of drugs; in the field of translational medicine, it can be used in preclinical studies/evaluations of drugs, including pharmacology/efficacy, toxicology/toxicity generation, and safety evaluation.
5. Strong Technical Support
InnoModels Biotechnology has an experienced technical team with rich testing experience and technical support capability, which can provide users with all-round technical support and services. Whether it is experimental design, sample processing or data analysis, the team can provide professional guidance and assistance to ensure that users can fully utilize the advantages of the Luminex platform to achieve high-quality research results.
Conclusion
The Luminex platform of InnoModels Biotechnology has shown great potential and value in scientific research and clinical applications due to its multi-detection capability, high sensitivity and specificity, easy and efficient operation, and wide range of applications. The platform not only provides efficient and accurate bioassay solutions for researchers, but also provides strong technical support for the research and development of tumor and tumor immunotherapy. It is believed that in the future, the Luminex platform will be applied and promoted in more fields, bringing more convenience and protection to people's health and life.

Keyword:

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司